Financials

  • Market Capitalization 53.17 M
  • Employee 21
  • Founded 2015
  • CEO N/A
  • Website www.inmunebio.com
  • Headquarter Nevada, United States
  • FIGI BBG00LW94L98
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.69
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4301
ATYR
aTyr Pharma, Inc. - Common Stock
0.51 USD+2.00%-26.09%+8.51%-47.42%50.01 M USD
4305
MCRB
Seres Therapeutics, Inc. - Common Stock
5.17 USD-8.01%-32.77%-11.17%-37.18%49.56 M USD
4353
HYPD
Hyperion DeFi, Inc. - Common Stock
3.02 USD+1.68%+0.67%+4.86%-74.83%45.78 M USD
4372
RNXT
RenovoRx, Inc. - Common Stock
0.90 USD-1.10%-1.10%+7.14%-34.78%40.59 M USD

Notizie